HUMA

Humacyte Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↑ 8/10
  • Momentum↓ 1/10
Humacyte sales and earnings growth
HUMA Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 82.84%
  • FCF Y/Y↓ -15.33%
Humacyte gross and profit margin trends
HUMA Profitability
Good
  • Gross margin ↑ 60.50%
  • EPS margin↓ -2353.20%
  • ROIC↓ -24.70%
Humacyte net debt vs free cash flow
HUMA Risk
Great
  • Debt / Equity↓ -10.6
  • Debt / FCF↓ 0.3
  • Interest coverage↓ -2.5

Humacyte stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗